| Mariela Podolski, MD | |
|
433 S Main St Ste 327, West Hartford, CT 06110-2816 | |
| (860) 410-4007 | |
| (860) 955-4804 |
| Full Name | Mariela Podolski |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 433 S Main St Ste 327, West Hartford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023201589 | NPI | - | NPPES |
| 004025177 | Medicaid | CT | |
| 004041729 | Medicaid | CT |
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
Tobacco smoking involves a physiological addiction to nicotine for a lot of people. Quitting can cause some nasty symptoms due to the withdrawal of nicotine.
Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.
The Health Protection Agency (HPA) in the UK has announced that the vet who became ill after working on the farm where an outbreak of bird flu has occurred, has tested negative for the virus.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
› Verified 8 days ago
| Entity Name | Prospect Rockville Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205283538 PECOS PAC ID: 4880988211 Enrollment ID: O20160913001880 |
News Archive
Tobacco smoking involves a physiological addiction to nicotine for a lot of people. Quitting can cause some nasty symptoms due to the withdrawal of nicotine.
Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.
The Health Protection Agency (HPA) in the UK has announced that the vet who became ill after working on the farm where an outbreak of bird flu has occurred, has tested negative for the virus.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
› Verified 8 days ago
| Entity Name | Prospect Manchester Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316394638 PECOS PAC ID: 9234423625 Enrollment ID: O20160926000570 |
News Archive
Tobacco smoking involves a physiological addiction to nicotine for a lot of people. Quitting can cause some nasty symptoms due to the withdrawal of nicotine.
Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.
The Health Protection Agency (HPA) in the UK has announced that the vet who became ill after working on the farm where an outbreak of bird flu has occurred, has tested negative for the virus.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariela Podolski, MD 44 Fieldstone Dr, South Glastonbury, CT 06073-3718 Ph: (860) 707-4880 | Mariela Podolski, MD 433 S Main St Ste 327, West Hartford, CT 06110-2816 Ph: (860) 410-4007 |
News Archive
Tobacco smoking involves a physiological addiction to nicotine for a lot of people. Quitting can cause some nasty symptoms due to the withdrawal of nicotine.
Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.
The Health Protection Agency (HPA) in the UK has announced that the vet who became ill after working on the farm where an outbreak of bird flu has occurred, has tested negative for the virus.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.
› Verified 8 days ago
Dr. Kenneth S Robson, M..D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18 N Main St, West Hartford, CT 06107 Phone: 860-561-4178 Fax: 860-561-4183 | |
Mr. Arshpreet Singh Gulati, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 65 Kane St, West Hartford, CT 06119 Phone: 860-523-3745 Fax: 860-523-3736 | |
Dr. Brian Christopher Eddy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 22 Hooker Dr, West Hartford, CT 06107 Phone: 860-679-6700 | |
Dr. Harriet A. Fellows, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 23 Woodpond Rd, West Hartford, CT 06107 Phone: 860-989-9100 | |
Dr. Walter Arnold Borden, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 N Main St, West Hartford, CT 06107 Phone: 860-561-1660 Fax: 860-561-1661 | |
Dr. Thomas Michael Hill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 801 Farmington Ave, West Hartford, CT 06119 Phone: 860-232-6951 Fax: 866-394-4132 |